Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 10, 2006, Pages 1262-1266

  Maár, Noémi ^a   Ergun, Erdem ^a   Luksch, Alexandra ^a   Stur, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Choroidal neovascularization; Pathological myopia; Photodynamic therapy; Treatment frequency

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FLUORESCEIN;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATION FUNCTION; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLIT LAMP; STATISTICAL SIGNIFICANCE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33749067610     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0246-6     Document Type: Article

References (27)

1. Andrade RE, Farah ME, Costa RA (2003) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease. Am J Ophthalmol 136:1179-1181
2. Avila MP, Weiter JJ, Jalkh AE et al (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573-1581
3. Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M (2004) Photodynamic therapy of subfoveal choroidal neovascularisation in high myopia in a clinical setting: Visual outcome in relation to age at treatment. Am J Ophthalmol 138:602-607
4. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy for choroidal neovascularization associated with pattern dystrophy. Retina 23:171-176
5. Canakis C, Conway MD, Livir-Rallatos C, Naaman GJ, Ratnakaram R, Men G, Peyman GA (2004) Ocular photodynamic therapy in choroidal neovascularization complicating idiopathic central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 35:168-171
6. Ergun E, Tittl M, Stur M (2004) Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 122:37-41
7. Ergun E, Heinzl H, Stur M (2004) Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularisation in pathologic myopia. Am J Ophthalmol 138:434-438
8. Fried M, Siebert A, Meyer-Schwickerath G (1981) A natural history of Fuchs' spot: A long-term follow-up study. Doc Ophthalmol 28:215-221
9. Hampton GR, Kohen D, Bird AC (1983) Visual prognosis of disciform degeneration in myopia. Ophthalmology 90:923-926
10. Hollanday JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388-391
11. Karacorlu M, Karacorlu S, Ozdemir H, Mat C (2002) Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 134:360-366
12. Karadimas P, Bouzas EA (2004) Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks. Ophthalmic Surg Lasers Imaging 35:78-80
13. Postelmans L, Pasteels B, Coquelet P, El Ouardighi H, Verougstraete C, Schmidt-Erfurth U (2004) Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 138:803-808
14. Rogers AH, Greenberg PB, Martidis A, Puliafito CA (2003) Photodynamic therapy of polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers Imaging 34:60-63
15. Shanmugam MP, Agarwal M (2005) RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis. Ind J Ophthalmol 53:61-63
16. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguwt B et al (2000) A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularisation in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 118:327-336
17. Snyers B, Verougstraete C, Postelmans L, Leys A, Hykin P (2004) Photodynamic therapy of subfoveal neovascular membrane type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 137:812-819
18. Spaide RF, Donsoff I, Lam DL, Yannuzzi LA, Jampol LM, Slakter J, Sorenson J, Freund KB (2002) Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 22:529-535
19. Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA, Fisher Y (2002) Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 22:545-549
20. Spaide RF, Martin ML, Slakter J, Yannuzzi LA, Sorenson J, Guyer DR, Freund KB (2002) Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 134:62-68
21. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomised clinical trials-TAP report 1. Arch Ophthalmol 117:1329-1345
22. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: two-year results of 2 randomised clinical trials-TAP report 2. Arch Ophthalmol 119:198-207
23. Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularisation in age-related macular degeneration: Two year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularisation-Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 131:541-560
24. Verteporfin in Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial-VIP report No. 1. Ophthalmology 108:841-852
25. Verteporfin Roundtable Participants (2005) Guidelines for using Verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: Update. Retina 25:112-134
26. Wachtlin J, Heimann H, Behme T, Foerster MH (2003) Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefe's Arch Clin Exp Ophthalmol 241:899-906
27. Wachtlin J, Wehner A, Heimann H, Foerster MH (2004) Photodynamische Therapie mit Verteporfin bei Patienten mit idiopathischer chorioidaler Neovaskularisation. 2-Jahres-Ergebnisse. Ophthalmologe 101:489-495